Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Disease)

This study has been terminated.

(Funding term ended)

Sponsor:

Collaborator:

Information provided by (Responsible Party):

Jonsson Comprehensive Cancer Center

ClinicalTrials.gov Identifier:

NCT00612066

First received: February 8, 2008

Last updated: July 27, 2012

Last verified: July 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	No date given
Primary Completion Date:	December 2010 (Final data collection date for primary outcome measure)